HIMCH
CNCE

Hartford Investment Management Co (HIMCO)’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Hartford Investment Management Co (HIMCO)’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-14,422
Closed -$214K – 801
2018
Q3 		$214K Sell
14,422
-962
-6% -$15.1K 0.01% 738
2018
Q2 		$259K Buy
+15,384
New +$299K 0.01% 671

Other funds holding CNCE

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hartford Investment Management Co (HIMCO)'s CNCE Position: Q4 2018 in Review

Hartford Investment Management Co (HIMCO) sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q4 2018, closing a stake of 14,422 shares — an estimated $214K sold.

Hartford Investment Management Co (HIMCO) first reported a position in CNCE in Q2 2018 and held it in 2 quarters. The position peaked at $259K in Q2 2018. 93 funds tracked by Wall St. Rank hold CNCE as of Q4 2018.

  • Hartford Investment Management Co (HIMCO) reported no remaining Concert Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
  • Hartford Investment Management Co (HIMCO) sold 14,422 Concert Pharmaceuticals, Inc. shares in Q4 2018, an estimated $214K.
  • Hartford Investment Management Co (HIMCO) first reported a position in Concert Pharmaceuticals, Inc. in Q2 2018 and held it in 2 quarters.
  • Hartford Investment Management Co (HIMCO)'s Concert Pharmaceuticals, Inc. position peaked at $259K in Q2 2018.
  • 93 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q4 2018.

Based on Hartford Investment Management Co (HIMCO)'s 13F filing for Q4 2018, filed 4 Feb 2019.